Answers are grounded in this paper and cite their sources.
Disease-modifying drugs significantly decreased new CL development and cortical atrophy progression compared with untreated patients, with faster and more pronounced effects seen with sc IFN beta-1a than with im IFN beta-1a or GA.
No takes yet. Share an insight, caveat, or question.
Calabrese et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: